Stocks Health care SPRC

NASDAQ · Health care

SciSparc Ltd. (SPRC)

SciSparc Ltd. reported revenue of $1.3M in fiscal 2024, down 54.6% from a year earlier. It posted a net loss of $6.3M. At December 31, 2024 it held $1.5M in cash. Its latest periodic report to the SEC is the annual report (foreign issuer, amended) (20-F/A) filed on August 19, 2026.

Watch SPRC in 60 seconds

Follow SPRC

Free, no password. An email when SPRC files with the SEC.

Key facts about SciSparc Ltd.

Net worth

SciSparc Ltd. has a market value (market cap) of $229.9K at the latest share price, and shareholders' equity of $8.2M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

In fiscal 2024 revenue was $1.3M (-54.6% year on year), with a net loss of $6.3M.

Cash flow

In fiscal 2024 operations used $5.1M of cash.

Latest report

The latest periodic report (annual report (foreign issuer, amended), 20-F/A) was filed with the SEC on August 19, 2026 and covers the period to December 31, 2025. Open on SEC EDGAR

What SciSparc Ltd. does

SciSparc Ltd. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker SPRC.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Where SPRC ranks in Health care

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Health care

Latest SEC filings

What SciSparc Ltd. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. September 30, 2026
   Foreign issuer update 6-K
2. September 24, 2026
   Foreign issuer update 6-K
3. September 2, 2026
   Foreign issuer update 6-K
4. August 26, 2026
   Foreign issuer update 6-K
5. August 24, 2026
   Foreign issuer update 6-K
6. August 19, 2026
   Form F-3/A filing F-3/A
7. August 19, 2026
   Annual report (foreign issuer, amended) 20-F/A · period to December 31, 2025
8. August 18, 2026
   Foreign issuer update 6-K
9. August 12, 2026
   Foreign issuer update 6-K
10. August 5, 2026
    Foreign issuer update 6-K

Recent insider filings (Forms 3, 4 and 144): 10, the latest on July 13, 2026. Insider transactions on SEC

Insider trades

What the people running SciSparc Ltd. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns SPRC

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

No holder of 5% or more has filed about this company in that window.

Latest filings below 5%: L.I.A. Pure Capital Ltd. 0% (May 15, 2026); Ronen Fatal 0% (March 16, 2026); Eli Zamir 0% (March 16, 2026); Nissim Daniel 0% (March 9, 2026).

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

1 insiders reported holding 10,596 shares in total, about $4.2K at the last price.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about SPRC

What does SciSparc Ltd. do?

SciSparc Ltd. is a company in the Health care sector, listed on NASDAQ as SPRC. Its shares trade on NASDAQ under the ticker SPRC.

What is SciSparc Ltd.'s net worth?

SciSparc Ltd. has a market value (market cap) of $229.9K at the latest share price, and shareholders' equity of $8.2M on its balance sheet at December 31, 2024. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is SciSparc Ltd. profitable?

No. In fiscal 2024 it reported a net loss of $6.3M on revenue of $1.3M.

How much revenue does SciSparc Ltd. make?

In fiscal 2024 SciSparc Ltd. reported revenue of $1.3M. That is 54.6% less than a year earlier.

When did SciSparc Ltd. last report?

Its most recent periodic report is the annual report (foreign issuer, amended) (20-F/A) filed on August 19, 2026. It covers the period to December 31, 2025. Its newest filing of any kind is the foreign issuer update from September 30, 2026.

Similar companies

Compare SPRC with

Compare SPRC with any company

Follow SPRC

Get an email when SciSparc Ltd. files with the SEC: results, executive changes, material agreements and annual reports.

Follow SPRC

Free, no password. An email when SPRC files with the SEC.

Where the numbers come from

Financial figures are the values SciSparc Ltd. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.